In fact, serum levels of this nuclear protein are higher in diabetic patients with PAD, compared to diabetic patients without PAD, and plasma levels of HMGB1 correlated with clinical severity of the disease [57,87]. The gene discussed is HMGB1; the disease is peripheral arterial disease.